Zobrazeno 1 - 10
of 334
pro vyhledávání: '"Henry L Gomez"'
Autor:
Henry L Gomez, Carlos A. Castaneda, Miluska Castillo, James Reuben, Hui Gao, Nnacy Suarez, Luis A. Bernabe, Jose M. Cotrina, Jorge Dunstan, Marco Velarde, Julio Abugattas, Henry Guerra
Publikováno v:
Asian Pacific Journal of Cancer Care, Vol 6, Iss 4, Pp 373-377 (2021)
Objective: Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) provide tumor information in breast cancer. Our objective was to characterize CTCs, and contrasted them with ctDNA PIK3CA mutation in 24 triple-negative breast cancer (TNBC).
Externí odkaz:
https://doaj.org/article/ecf8a602a27d4245862888f8dff90cdc
Autor:
Gabriel De-la-Cruz-Ku, Marianne Luyo, Zaida Morante, Daniel Enriquez, Mecker G Möller, Diego Chambergo-Michilot, Lucero Flores, Renato Luque, Antonella Saavedra, Miguel E Eyzaguirre-Sandoval, María G Luján-Peche, Naysha Noel, Hafid Calderon, Cesar Razuri, Hugo A Fuentes, Jose Manuel Cotrina, Silvia P Neciosup, Jhajaira Araujo, Alexandra Lema, Joseph Pinto, Henry L Gomez, Bryan Valcarcel
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237811 (2020)
BackgroundEpidemiological studies commonly identify the clinical characteristics and survival outcomes of patients with breast cancer at five years. Our study aims to describe the sociodemographic, clinicopathological characteristics and determine th
Externí odkaz:
https://doaj.org/article/4b4932a0667a4238a298013fd3026fc6
Autor:
Lizeth I Tamayo, Tatiana Vidaurre, Jeannie Navarro Vásquez, Sandro Casavilca, Jessica I Aramburu Palomino, Monica Calderon, Julio E Abugattas, Henry L Gomez, Carlos A Castaneda, Sikai Song, Daniel Cherry, Garth H Rauscher, Laura Fejerman
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0201287 (2018)
Latina women in the U.S. have relatively low breast cancer incidence compared to Non-Latina White (NLW) or African American women but are more likely to be diagnosed with the more aggressive "triple negative" breast cancer (TNBC). Latinos in the U.S.
Externí odkaz:
https://doaj.org/article/c9cc2d8294b44cf9aff4467364fadcaa
Autor:
Nicholas C. Turner, Mafalda Oliveira, Sacha J. Howell, Florence Dalenc, Javier Cortes, Henry L. Gomez Moreno, Xichun Hu, Komal Jhaveri, Petr Krivorotko, Sibylle Loibl, Serafin Morales Murillo, Meena Okera, Yeon Hee Park, Joohyuk Sohn, Masakazu Toi, Eriko Tokunaga, Samih Yousef, Lyudmila Zhukova, Elza C. de Bruin, Lynda Grinsted, Gaia Schiavon, Andrew Foxley, Hope S. Rugo
Publikováno v:
New England Journal of Medicine. 388:2058-2070
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfd11470d58e0668b288ffbfb9d29818
https://doi.org/10.1056/nejmoa2214131
https://doi.org/10.1056/nejmoa2214131
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rossana Ruiz, Mariana Serrano, Eloy F. Ruiz, Raul Mantilla, Natalia Valdivieso, Mivael Olivera, Manuel Alvarez, Luis Mas, Henry L. Gomez
Publikováno v:
Revista Peruana de Medicina Experimental y Salud Pública, Vol 34, Iss 2, Pp 218-27 (2017)
Objective. To determine the clinical and histological characteristics and prognostic factors of cervical cancer (CC) in young Peruvian patients. Materials and methods. Retrospective analysis of patients younger than 35 years old diagnosed with CC bet
Externí odkaz:
https://doaj.org/article/19483bca22354f1ebd99c83b6cdac293
Autor:
Guillermo Arturo, Valencia, Patricia, Rioja, Zaida, Morante, Rossana, Ruiz, Hugo, Fuentes, Carlos A, Castaneda, Tatiana, Vidaurre, Silvia, Neciosup, Henry L, Gomez
Publikováno v:
World Journal of Clinical Oncology. 13:219-236
Triple-negative breast cancer (TNBC) is a highly complex, heterogeneous disease and historically has limited treatment options. It has a high probability of disease recurrence and rapid disease progression despite adequate systemic treatment. Immunot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55216374490dde53f2a2bea9b2ea4aa1
https://doi.org/10.5306/wjco.v13.i3.219
https://doi.org/10.5306/wjco.v13.i3.219
Autor:
Serena Di Cosimo, Chiara M. Ciniselli, Sara Pizzamiglio, Vera Cappelletti, Marco Silvestri, Sarra El-Abed, Miguel Izquierdo, Mohammed Bajji, Paolo Nuciforo, Jens Huober, David Cameron, Stephen Chia, Henry L. Gomez, Marilena V. Iorio, Andrea Vingiani, Giancarlo Pruneri, Paolo Verderio
Publikováno v:
Scientia
Cáncer de mama HER2 positivo; MicroARN circulante; Tratamiento neoadyuvante Càncer de mama HER2-positiu; MicroARN circulant; Tractament neoadjuvant HER2-positive breast cancer; Circulating microRNA; Neoadjuvant treatment Background: The absence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51373147bb903e68d3d82555b413b94d
https://hdl.handle.net/11351/9137
https://hdl.handle.net/11351/9137
Autor:
Olivia, Pagani, Barbara A, Walley, Gini F, Fleming, Marco, Colleoni, István, Láng, Henry L, Gomez, Carlo, Tondini, Harold J, Burstein, Matthew P, Goetz, Eva M, Ciruelos, Vered, Stearns, Hervé R, Bonnefoi, Silvana, Martino, Charles E, Geyer, Claudio, Chini, Fabio, Puglisi, Simon, Spazzapan, Thomas, Ruhstaller, Eric P, Winer, Barbara, Ruepp, Sherene, Loi, Alan S, Coates, Richard D, Gelber, Aron, Goldhirsch, Meredith M, Regan, Prudence A, Francis
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb081c4bd1ec56269065c4f686c173a
https://hdl.handle.net/11390/1243971
https://hdl.handle.net/11390/1243971
Autor:
Debbie M Jakubowski, Mauricio Lema-Medina, Juan Enrique Bargallo-Rocha, Fernando Herazo-Maya, Lisandro Luis Benitez Gil, Federico Coló, Carola Allemand, Henry L. Gomez, Mauricio Leon, Roberto Jorge Billinghurst, Raquel Gerson Cwilich, Francisco Jose Terrier, Ignacio Leonardo McLean, Calvin Chao, Sergio C Oliveira, Silvia Falcon, Aníbal Roberto Núñez de Pierro, Roberto Eduardo Castaño
Publikováno v:
JCO Global Oncology
PURPOSEWe present a physician survey of the impact of 21-gene Breast Recurrence Score test results on treatment decisions in clinical practice in Latin America.METHODSThis prospective survey enrolled consecutive patients at 14 sites in Argentina, Col
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::159d945b52e4dd1fadd325dc01b7f16d
https://doi.org/10.1200/go.21.00008
https://doi.org/10.1200/go.21.00008